Mitochondrial dysfunction: A promising therapeutic target for liver diseases

Area of Science:

• Hepatology
• Mitochondrial Biology
• Cellular Metabolism

Background:

• The liver relies on mitochondria for energy and detoxification.
• Liver diseases are characterized by mitochondrial damage, impaired ATP production, and oxidative stress.
• Mitochondrial dysfunction contributes to inflammation and cell death in hepatocytes.

Purpose of the Study:

• To review the mechanisms of mitochondrial dysfunction in acute and chronic liver diseases.
• To explore the role of mitochondrial DNA as a biomarker for liver disease progression.
• To discuss mitochondrion-targeted therapies for liver disease treatment.

Main Methods:

• Literature review of studies on mitochondrial dysfunction in liver diseases.
• Analysis of mechanisms linking mitochondrial damage to liver pathology.
• Synthesis of current knowledge on therapeutic strategies targeting mitochondria.

Main Results:

• Mitochondrial lesions, DNA damage, and impaired dynamics are hallmarks of liver disease.
• Oxidative stress from mitochondria exacerbates liver injury and promotes cell death.
• Mitochondrial DNA shows potential as a non-invasive biomarker for liver disease progression.

Conclusions:

• Mitochondrial dysfunction is a central mechanism in the pathogenesis of diverse liver diseases.
• Therapeutic interventions focused on mitochondria hold promise for treating liver conditions.
• Further research into mitochondrial biomarkers could improve patient risk stratification.